Renal Dyslipidemia and Medical Nutrition Therapy

Abstract

Arteriosclerotic cardiovascular disease is the most important cause of morbidity and mortality in Chronic Renal Failure (CRF) patients. In End-Stage Renal Failure, hypertriglyceridemic lipid abnormalities are quite common. Some of the lipoprotein disorders are frequently seen as a fraction. Most notable is the increased very low density lipoprotein (VLDL) cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, intermediate-density lipoprotein (IDL) cholesterol and decreased high-density lipoprotein (HDL) cholesterol. In these patients blood lipid profile should be regulated and appropriate medical nutrition therapy should be applied for prevention from cardiovascular diseases.